Supply chain considerations for M&A transactions
Future of Life Sciences Supply Chain: second issue
The life sciences industry continues to actively pursue mergers, acquisitions, and divestitures, which can bring about major changes for supply chain organizations. In this paper, which is the second issue of the future of life sciences supply chain series, we explore:
- The current M&A transaction landscape in the industry
- Key factors that supply chain leaders need to consider when integrating or separating assets
- How to increase readiness for future transactions
- Important lessons for supply chain leaders
Supply chain leaders should assess their current operations and identify areas for improvement. By investing in digital tools and processes, adopting a risk-based approach, and prioritizing sustainability, businesses can build more resilient and agile supply chains that can withstand future disruptions and deliver value to customers.
At KPMG, we have a broad range of functional and industry experience that can address your supply chain needs from strategy through execution. Read more to find out how we can help your organization.
Dive into our thinking:
Supply chain consideration for M&A transactions
Download PDFExplore more
Insight
The Connected Supply Chain
The Future of the Life Sciences Supply Chain Series: Issue No. 1
Insight
The future of supply chain
Insights to help you find strength and resilience as you address growing multi-national regulation and prepare for an evolving future.
Insight
Healthcare and life sciences M&A: Poised for a rebound?
After a wild few years for HCLS, there’s reason for optimism and some new opportunities—if you know where to look.
Insight
Life Sciences Operations
Improving our clients Regulatory, Quality, & Operations functions, addressing business needs with process transformation and technology enablement
Meet our team
